Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | Ca-A Cancer Journal for Clinicians | 2018 | 41.6K |
Global cancer statistics | Ca-A Cancer Journal for Clinicians | 2011 | 26.4K |
Global cancer statistics, 2012 | Ca-A Cancer Journal for Clinicians | 2015 | 20.7K |
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | International Journal of Cancer | 2015 | 19.3K |
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) | European Journal of Cancer | 2009 | 16.1K |
Global cancer statistics, 2002 | Ca-A Cancer Journal for Clinicians | 2005 | 14.4K |
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Journal of the National Cancer Institute | 2000 | 13.6K |
Cancer statistics, 2016 | Ca-A Cancer Journal for Clinicians | 2016 | 13.1K |
Cancer statistics, 2019 | Ca-A Cancer Journal for Clinicians | 2019 | 12.7K |
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | International Journal of Cancer | 2010 | 12.1K |
Cancer Statistics, 2017 | Ca-A Cancer Journal for Clinicians | 2017 | 12K |
Cancer statistics, 2018 | Ca-A Cancer Journal for Clinicians | 2018 | 12K |
Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics | British Journal of Cancer | 1972 | 11.4K |
Cancer statistics in China, 2015 | Ca-A Cancer Journal for Clinicians | 2016 | 11.3K |
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries | Ca-A Cancer Journal for Clinicians | 2021 | 11.2K |
Cancer statistics, 2010 | Ca-A Cancer Journal for Clinicians | 2010 | 11K |
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Cytotherapy | 2006 | 11K |
Cancer statistics, 2013 | Ca-A Cancer Journal for Clinicians | 2013 | 10.3K |
Cancer statistics, 2015 | Ca-A Cancer Journal for Clinicians | 2015 | 10.2K |
Cancer statistics, 2020 | Ca-A Cancer Journal for Clinicians | 2020 | 10.2K |
Cancer statistics, 2014 | Ca-A Cancer Journal for Clinicians | 2014 | 9.9K |
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology | Journal of the National Cancer Institute | 1993 | 9.9K |
Cancer statistics, 2012 | Ca-A Cancer Journal for Clinicians | 2012 | 9.4K |
Cancer statistics, 2008 | Ca-A Cancer Journal for Clinicians | 2008 | 8.9K |
Statistical aspects of the analysis of data from retrospective studies of disease | Journal of the National Cancer Institute | 1959 | 8.7K |